Alcohol Dependence

Follow
Scientists in a lab watch rats reject alcohol bottles after tirzepatide treatment from Mounjaro, highlighting new hope for alcoholism therapy.
Image generated by AI

New study offers hope for weight loss drugs against alcoholism

Reported by AI Image generated by AI

A new study from the University of Gothenburg shows that tirzepatide, the active ingredient in the diabetes and weight loss drug Mounjaro, reduces alcohol intake and relapse-like behaviors in rats and mice. This builds on prior research on semaglutide in Ozempic and Wegovy, which curbs alcohol consumption in humans. Researchers hope for similar effects in patients with alcohol dependence.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline